3 completed, 2 unknown. 5 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Unknown 2 |
| Phase 1 | 3 | Unknown 2, Completed 1 |
Follow Thromboangiitis Obliterans: new trials by email Literature Review of Thromboangiitis Obliterans trials Research Report on Thromboangiitis Obliterans
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Efficacy and Safety of CLBS12 in Patients with Critical Limb Ischemia (CLI) CLBS12, SOC - Critical Limb Ischemia, Buerger Disease | Phase 2 | Completed | Lisata Therapeutics, Inc. | 33 | 2017-11-01 | 2024-10-09 |
| Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia ADRC injection, ADRC isolation, Liposuction - Critical Limb Ischemia, Arteriosclerosis Obliterans | Phase 1 / Phase 2 | Unknown | Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | 9 | 2016-07-01 | 2016-08-12 |
| A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease Allogeneic Mesenchymal Stem Cells - Critical Limb Ischemia, Buerger's Disease | Phase 2 | Completed | Stempeutics Research Pvt Ltd | 90 | 2012-01-01 | 2016-09-13 |
| Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia ResQ processed bone marrow sample, Ficoll conventional cell processing method - Critical Limb Ischemia, Peripheral Arterial Disease | Phase 1 / Phase 2 | Unknown | Xuanwu Hospital, Beijing | 50 | 2011-10-01 | 2011-10-12 |
| Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia Endothelial progenitor cells intramuscular implant - Critical Limb Ischemia | Phase 1 / Phase 2 | Completed | Fondazione IRCCS Policlinico San Matteo di Pavia | 8 | 2009-01-01 | 2012-06-14 |
Chronic Limb-Threatening Ischemia (5) · Peripheral Arterial Disease (2) · Arteriosclerosis Obliterans (1) · Diabetic Angiopathies (1)
Arterial Occlusive Diseases (5) · Arteriosclerosis (5) · Atherosclerosis (5) · Cardiovascular Diseases (5) · Chronic Disease (5) · Disease Attributes (5) · Ischemia (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Peripheral Vascular Diseases (5) · Vascular Diseases (5) · Vasculitis (5) · Peripheral Arterial Disease (3) · Diabetes Complications (1) · Diabetes Mellitus (1)
Cell- and Tissue-Based Therapy (1) · Lipectomy (1) · Standard of Care (1) · betibeglogene autotemcel (1)
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Lisata Therapeutics, Inc. (1) · Stempeutics Research Pvt Ltd (1) · Xuanwu Hospital, Beijing (1)
China (1) · India (1) · Italy (1) · Japan (1) · Russia (1)
Andrey A Kalinin, MD, PhD (1) · Andrey A Pulin, MD, PhD (1) · Attilio Odero, Professor (1) · Dr Alfred Augustine (1) · Dr Anirban Chatterjee (1) · Dr Anita Dhar (1) · Dr Murali Krishna (1) · Dr Radhakrishnan R (1) · Dr Rajiv Parakh (1) · Dr Rajkumar M (1) · Dr Sanjay Desai (1) · Dr Santanu Dutta (1) · Dr Vidyasagaran T (1) · Evgeny R Lysenko, MD, PhD, Prof (1) · Kristen K Buck, MD (1)